Coming Soon

Feature

Progress

Priority Review Voucher valuation model

Most companies and outlets assume the current value of a priority review voucher based on the last public sale price. I will be creating a model providing PRV valuations using multiple metrics.

⁠

Overview of clinical stage assets that may be eligible for priority review vouchers

⁠

Overview of potential purchasers of priority review vouchers

⁠

FDA CRL Dashboard

⁠

There are no rows in this table

⁠

Follow on X for updates

PRVWatch

⁠

Want to print your doc?
This is not the way.

Try clicking the ⋯ next to your doc name or using a keyboard shortcut (

CtrlP

) instead.